IceCure Medical (ICCM) Cash from Financing Activities (2020 - 2026)
IceCure Medical (ICCM) posted quarterly Cash from Financing Activities of $3.5 million for Q1 2026, up 38.06% year-over-year from $2.6 million in Q1 2025, and down 4.92% quarter-over-quarter from $3.7 million in Q4 2025.
IceCure Medical (ICCM) Cash from Financing Activities (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has reported Cash from Financing Activities for 7 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 38.06% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $16.8 million (up 88.61% YoY), while the FY2025 annual figure was $15.8 million, up 72.35% from the prior year.
- Cash from Financing Activities slipped to $3.5 million in Q1 2026 per ICCM's latest filing, from $3.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $13.6 million in Q4 2022 and bottomed at $68000.0 in Q4 2023.
- Historically, Cash from Financing Activities has averaged $3.8 million across 5 years, with a median of $2.8 million in 2024.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities sank 99.5% — and 2024, when it jumped 1519.12%.
- IceCure Medical's Cash from Financing Activities stood at $13.6 million in 2022, then tumbled by 99.5% to $68000.0 in 2023, then surged by 1519.12% to $1.1 million in 2024, then jumped by 237.87% to $3.7 million in 2025, then slipped by 4.92% to $3.5 million in 2026.
- Business Quant data shows ICCM's Cash from Financing Activities at $3.5 million in Q1 2026, $3.7 million in Q4 2025, and $7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | IceCure Medical | 6.61 Mn | -5.43 Mn | 253,000.00 | 7.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.78 Mn |
| Jun 30, 2026 | 7.78 Mn |
| Mar 31, 2026 | 3.54 Mn |
| Mar 31, 2026 | 3.54 Mn |
| Dec 31, 2025 | 3.72 Mn |
| Dec 31, 2025 | 3.72 Mn |
| Sep 30, 2025 | 7.47 Mn |
| Sep 30, 2025 | 7.47 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.84 Mn |
| Mar 31, 2024 | 2.84 Mn |